 
Nephrology Quiz and Questionnaire: Fluid and Electrolyte and Glomerulonephritis Cases
Flash slide/audio
(ASN Clinical Nephrology Conference, November, 2007)
Emmett: Case 2: Was it laxative that the patient drank? The wife said it was magnesium citrate. Anyway, now he's comatose with normal electrolytes. Then his creatinine goes up and his serum
osmolality does, also, with positive ketones, but no acidosis. How would you treat him? Case 6: A woman who takes Topamax for migraines presents with hyponatremia and hyperchloremic acidosis. How
does topiramate affect the kidney and what indications is it being used for?
Radhakrishnan: Case 4: Young AA woman with nephrotic syndrome and elevated ANA. OK, it's membranous: lupus or not? If lupus, how do we treat it? Case 8: Middle-aged female with acute
fulminant GN picture and a creatinine of 10. Is it worth treating her? What if she has anti-GBM? What if she has MPO-ANCA?.
(more...)
|
Preparing for the New Medical Director Responsibilities
Flash slide/audio
(Renal Network 9/10 - RPA Conference, October 2008)
Overview and Introduction to the Nework Role in QAPI and CMS Compliance
Peter B. DeOreo, MD (Introduced by George Aronoff, MD and Alan S. Kliger, MD)
QAPI: Quality and Safety - The Big Picture
Alan S. Kliger, MD
The Medical Director, the IDT and the Medical Staff
J. Michael Lazarus, MD
Governance, Administrative and Supervisory Issues for the Medical Director under the New CfC
David Van Wyck, MD
Legal Implications for the Medical Director Under the New CfC
James Riley, Jr.
Panel Discussion: Rebuttals, Rejoinders and Reality
Drs. De Oreo, Kliger, Van Wyck, Lazarus and Mr. Riley. Moderators: Drs. Aronoff and Wish
Water: What's New and What to Do (Parts 1 and 2)
James Baker
(Dr. Priti Patel's talk to be added soon).
(more...)
|
 |
 |
 |
|
 |
Annual Dialysis Conference 2008
now in MP3
|
AUDIOFILE
LIST (Annual Dialysis Conference 2008)
(16 talks)
Towards Animal Model Standardization in PD
Andrzej Breborowicz, MD., Bengt Lindholm, MD., Harold Moore, MA.,Andrzej Breborowicz, MD., Dirk Struijk, MD
The Evidence and Practice of HD
Madhukar Misra, MD., Christopher Chan, MD., Amit Sharma, MD
Theory and Practice of Anticoagulation
Anaadriana Zakarija, MD., Andrew Davenport, MD., Karl-Georg Fischer, MD., Suhail Ahmad, MD
PD and HD Controversies
Anatole Besarab, MD., Brendan McCormick, MD.,Brendan McCormick, MD., Salim Mujais, MD
Managing Comorbidites in PD Patients
Kul Aggarwal, MD., Pranay Kathuria, MD., Kamyar Kalantar-Zadeh, MD., Thomas Golper, MD
|
|
 |
|
|
Hypertension-associated kidney disease: perhaps no more.
Is the increased risk of kidney disease in African Americans due to more hypertension or to some other genetic susceptibility. Freedman and Sedor explore these relationships
in the November 2008 issue of the J Am Soc Nephrol (JASN)
(more...) |
|
|
Acid-base disturbances in gastrointestinal disease
Gennari and Weise first review ion transport at all levels of the gut, and then show how this translates into acid-base disturbances with vomiting, inflammatory or secretary diarrhea, villous ademona,
and with ileostomy drainage;
from the November issue of the Clinical J Am Soc Nephrol (CJASN)
(more...) |
|
|
Nonphosphate-binding effects of sevelamer -- are they of clinical relevance?
Marangon, Lindholm, and Stenvinkel discuss the potential clinical importance of sevelamer's ability to lower LDL cholesterol, infrom endothelial function, and modulate inflammation and oxidative
stress;
from the Sept/Oct issue of Seminars in Dialysis.
(more...) |
|
|
Managing cancer risk and decision making after kidney transplantation.
Webster and colleagues discuss primary prevention, immunization, chemoprevention, and screening programs addressing management of posttransplant cancer risk;
in the November issue of the Am J Transplant.
(more...) |
|
|
Low molecular weight heparin for hemodialysis
Davenport talks about the problems, the benefits, and the costs of LMWH, which is now used extensively in Europe. In the October issue of
Hemodialysis International.
(more...) |
|
|
What's new in the (drug) pipeline for transplantation?
Vincenti and Kirk discuss a whole series of new approaches that may modify the immune response more effectively to permit survival of renal allografts with less adverse impact on renal function; in
the Oct issue of the Am J Transplant.
(more...) |
|
|
Adverse renal and metabolic effects associated with oral sodium phosphate bowel preparation.
Although this is now well known, Heher et al review the latest information about this source of potential acute renal failure; especially important given the widespread use of this method of bowel
preparation;
from the September issue of the Clinical J Am Soc Nephrol (CJASN)
(more...) |
|
|
Sympathetic overactivity - the Cinderella of cardiovascular risk factors in dialysis patients
Vonend, Rump, and Ritz discuss the evidence for SNS overactivity in ESRD and what treatments may best mitigate this;
from the July/August issue of Seminars in Dialysis.
(more...) |
|
|
The aggravating mechanisms of aldosterone on kidney fibrosis
Remuzzi and colleagues discuss how aldosterone may promote kidney fibrosis, and the potential benefits of halting this process;
in the August 2008 issue of the J Am Soc Nephrol (JASN)
(more...) |
|
|
Pharmacogenetics of immunosuppressants: progress, pitfalls and promises
Cattaneo and colleagues review the data on polymorphisms of the thiopurine-S-methyltransferase and cytochrome
P450 3A5 genotypes, but also discuss new research on the genetic variation of the targets of immunosuppresant drugs;
in the July 2008 issue of the
Am J Transplant.
(more...) |
|
|
Exercise and Dialysis
Johansen reviews the evidence of what the benefits are, what are the best types to recommend, and the new recs from the American College of Sports Medicine and the AHA for older individuals and for
those with chronic diseases;
from the July issue of Hemodialysis International.
(more...) |
|
|
Treating elderly people with diabetes and stages 3 and 4 chronic kidney disease.
Abaterusso and colleagues discuss the realities and practical approaches of treating CKD in the elderly;
from the July issue of the Clinical J Am Soc Nephrol (CJASN)
(more...) |
|
50 years of beta blockade (review)
96